# Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain

> **NCT02866071** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Jason McMullan** · enrollment: 224 (estimated)

## Conditions studied

- Acute Traumatic Pain

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Placebo-Comparator

## Key facts

- **NCT ID:** NCT02866071
- **Lead sponsor:** Jason McMullan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-10-03
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02866071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02866071, "Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02866071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*